0001315406-15-000014.txt : 20150814
0001315406-15-000014.hdr.sgml : 20150814
20150814170314
ACCESSION NUMBER: 0001315406-15-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150813
FILED AS OF DATE: 20150814
DATE AS OF CHANGE: 20150814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO RAD LABORATORIES INC
CENTRAL INDEX KEY: 0000012208
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 941381833
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 ALFRED NOBEL DR
CITY: HERCULES
STATE: CA
ZIP: 94547
BUSINESS PHONE: 5107247000
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DR
CITY: HERCULES
STATE: CA
ZIP: 94547
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOETZ JOHN
CENTRAL INDEX KEY: 0001237945
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07928
FILM NUMBER: 151056907
MAIL ADDRESS:
STREET 1: BIO-RAD LABORATIORIES
STREET 2: 1000 ALFRED NOBEL DRIVE
CITY: HERCULES
STATE: CA
ZIP: 94547
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-13
0000012208
BIO RAD LABORATORIES INC
BIO, BIOB
0001237945
GOETZ JOHN
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES
CA
94547
0
1
0
0
EVP, Chief Operating Officer
Bio-Rad A Common Stock
2015-08-13
4
M
0
7000
62.47
A
57965.5476
D
Bio-Rad A Common Stock
2015-08-13
4
S
0
1999
146.75
D
55966.5476
D
Bio-Rad A Common Stock
2015-08-13
4
S
0
2559
147.57
D
53407.5476
D
Non-Qualified Stock Option (right to buy)
62.47
2015-08-13
4
M
0
7000
0
D
2016-04-03
Bio-Rad A Common Stock
7000
0
D
Includes 31.2067, 58.6524 and 60.3804 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/14, 3/31/15 and 6/30/15, respectively.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.21 to $147.19 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.35 to $147.75 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested in five equal annual installments beginning on April 3, 2007.
John Goetz
2015-08-14